03 Feb 2022


J.B.Chemicals & Pharmaceuticals Ltd. (JBCPL) is one of India’s leading pharmaceutical companies.
Trilegal represented JBCPL in acquiring certain brands, assets, employees and business relationships from Sanzyme Private Limited pertaining to its probiotics and reproductive health business (which includes brands such as Sporlac, Lobun, Oxalo and Nano Leo) for commercializing, marketing and sale in India.
The Trilegal team was led by Clarence Anthony, Harsh Maggon (Partners); Nidhi Singla, Sandhya Sridhar and Aditya Ravishankar (Associates). The TMT team was led by Jyotsna Jayaram (Partner); Thomas Vallianeth (Senior Associate); Akshaya Parthasarathy and Sanah Javed, (Associates). The labour team was led by Atul Gupta (Partner); Parvathy Tharamel (Senior Associate); and Pankaj Arora (Associate).
Other parties involved in the transaction were Shardul Amarchand Mangaldas advisor to the Seller and the Promoters.
For more information, please contact:
Sahil Wason
Tel: +91-8928008122
BD@Trilegal.com

Deal: Trilegal advises Iscon Balaji Foods on the INR 2,000 crores investment in it by Advent International and 360 ONE Alternates Asset Management (in multiple tranches)

Trilegal partners discuss how institutions depth, AI and cross-border agility are reshaping India’s legal market

Trilegal advised EPL on CCI approval for merger with Indovida India
Under the rules of the Bar Council of India, Trilegal is prohibited from soliciting work or advertising in any form or manner. By accessing this website, www.trilegal.com, you acknowledge that:
We prioritize your privacy. Before proceeding, we encourage you to read our privacy policy, which outlines the below, and terms of use to understand how we handle your data:
For more information, please read our terms of use and our privacy policy.